NEW YORK (360Dx) – While triple quadrupoles currently dominate the clinical mass spec market, interest is growing among researchers and clinicians in using high-resolution accurate mass (HRAM) instruments like Orbitraps and QTOFs for clinical assays.

Better accuracy and the ability to collect discovery data while simultaneously running clinical assays give HRAM instruments significant advantages compared to triple quadrupoles, said Ravinder Singh, director of the Mayo Clinic Endrocrine Laboratory and an expert in clinical mass spec.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.